Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Frankfurt - Delayed Quote EUR

Heidelberg Pharma AG (HPHA.F)

Compare

2.3100

-0.0100

(-0.43%)

As of 8:02:57 AM GMT+1. Market Open.

Investors in Heidelberg Pharma (ETR:HPHA) have unfortunately lost 40% over the last three years

As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand...

Simply Wall St. 11 days ago

HPHA.DE
-1.69%
Spotlight On 3 Penny Stocks With Market Caps Over US$100M

As global markets navigate a mixed landscape of rising treasury yields, fluctuating consumer confidence, and varied economic data across regions, investors are seeking opportunities that align with these dynamic conditions. Penny stocks, often smaller or newer companies, remain an intriguing option for those willing to explore beyond established market giants. Despite the term's outdated connotations, these stocks can offer significant potential when underpinned by strong financials and...

Simply Wall St. last month

HPHA.DE
-1.69%
9909.HK
Here's Why We're Watching Heidelberg Pharma's (ETR:HPHA) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Simply Wall St. last month

HPHA.DE
-1.69%
November 2024's Promising Penny Stocks To Consider

Global markets have recently shown resilience, with U.S. indexes approaching record highs and broad-based gains despite geopolitical tensions and policy uncertainties. In the context of these market dynamics, penny stocks—often representing smaller or newer companies—remain an intriguing area for investors seeking potential value. While the term "penny stock" may seem outdated, it still signifies opportunities in companies that can offer significant returns if they possess strong financial...

Simply Wall St. 2 months ago

VVCHF

HPHA.DE
-1.69%
Heidelberg Pharma Third Quarter 2024 Earnings: €0.13 loss per share (vs €0.002 profit in 3Q 2023)

Heidelberg Pharma ( ETR:HPHA ) Third Quarter 2024 Results Key Financial Results Revenue: €3.56m (up 59% from 3Q 2023...

Simply Wall St. 4 months ago

HPHA.DE
-1.69%
With 46% ownership, Heidelberg Pharma AG (ETR:HPHA) insiders have a lot at stake

Key Insights Insiders appear to have a vested interest in Heidelberg Pharma's growth, as seen by their sizeable...

Simply Wall St. 4 months ago

HPHA.DE
-1.69%
Shareholders in Heidelberg Pharma (ETR:HPHA) are in the red if they invested three years ago

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...

Simply Wall St. 5 months ago

HPHA.DE
-1.69%
Is Heidelberg Pharma (ETR:HPHA) In A Good Position To Invest In Growth?

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Simply Wall St. 7 months ago

HPHA.DE
-1.69%
Heidelberg Pharma First Quarter 2024 Earnings: €0.10 loss per share (vs €0.14 loss in 1Q 2023)

Heidelberg Pharma ( ETR:HPHA ) First Quarter 2024 Results Key Financial Results Revenue: €1.86m (down 10% from 1Q...

Simply Wall St. 9 months ago

HPHA.DE
-1.69%
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the first patient has been enrolled in the Austere environments Consortium for Enhanced Sepsis Outcomes' (ACESO) U.S. government-supported PROTECT multinational platform trial for early COVID-19 outpatient treatment. RHB-107 (upamostat) is the first drug being tested in this platform study. Funded through non-dilutive external sources, including the U.S. Department of D

PR Newswire 9 months ago

RDHL

HPHA.F
-0.43%

Performance Overview

Return	HPHA.F	DAX P
YTD	-0.43%	+11.95%
1-Year	-20.62%	+30.20%
3-Year	-44.93%	+51.30%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Heidelberg Pharma AG (HPHA.F)

Investors in Heidelberg Pharma (ETR:HPHA) have unfortunately lost 40% over the last three years

Spotlight On 3 Penny Stocks With Market Caps Over US$100M

Here's Why We're Watching Heidelberg Pharma's (ETR:HPHA) Cash Burn Situation

November 2024's Promising Penny Stocks To Consider

Heidelberg Pharma Third Quarter 2024 Earnings: €0.13 loss per share (vs €0.002 profit in 3Q 2023)

With 46% ownership, Heidelberg Pharma AG (ETR:HPHA) insiders have a lot at stake

Shareholders in Heidelberg Pharma (ETR:HPHA) are in the red if they invested three years ago

Is Heidelberg Pharma (ETR:HPHA) In A Good Position To Invest In Growth?

Heidelberg Pharma First Quarter 2024 Earnings: €0.10 loss per share (vs €0.14 loss in 1Q 2023)

RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study

Performance Overview